CDC45 and non-small cell lung carcinoma: In addition, knockdown of CDC45 expression inhibited the proliferation of non-small cell lung cancer (NSCLC) cells in vitro and in vivo and arrested cells in the G2/M phase of the cell cycle, which could be a novel therapeutic target for NSCLC (Huang et al., 2019).